Cargando…

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis

BACKGROUND & AIMS: Application of nucleoside analogues and hepatitis B immunoglobulin (HBIG) has reduced hepatitis B virus (HBV) recurrence rate after liver transplantation (LT) dramatically. Recent data suggests therapy without HBIG is also effective. We sought to evaluate the necessity of HBIG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peijie, Tam, Ngalei, Wang, Haochen, Zheng, Huanwei, Chen, Philip, Wu, Linwei, He, Xiaoshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125198/ https://www.ncbi.nlm.nih.gov/pubmed/25102072 http://dx.doi.org/10.1371/journal.pone.0104480

Ejemplares similares

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
por: Beckebaum, Susanne, et al.
Publicado: (2018)

Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
por: Wu, LinWei, et al.
Publicado: (2012)

Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?
por: Harmancı, Özgür, et al.
Publicado: (2014)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
por: Kim, Kyeong Deok, et al.
Publicado: (2021)

Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin
por: Ahn, Joseph, et al.
Publicado: (2011)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study
por: Yang, Anli, et al.
Publicado: (2017)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
por: Park, Gil-Chun, et al.
Publicado: (2020)

Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis
por: Lai, Quirino, et al.
Publicado: (2021)

Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
por: Hwang, Shin, et al.
Publicado: (2019)

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
por: Roche, Bruno, et al.
Publicado: (2022)

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
por: Maiwall, Rakhi, et al.
Publicado: (2016)

Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review
por: Hou, Yuchen, et al.
Publicado: (2018)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis
por: Han, Seunghoon, et al.
Publicado: (2017)

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B
por: Choi, Ho Joong, et al.
Publicado: (2017)

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
por: Cortesi, Paolo Angelo, et al.
Publicado: (2023)

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
por: Roche, Bruno, et al.
Publicado: (2015)

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Uremia, and Insulin-Dependent Diabetes
por: Hong, Xitao, et al.
Publicado: (2022)

The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence
por: VATANSEVER, Sezgin, et al.
Publicado: (2019)

Improved hepatitis A and hepatitis B vaccination strategy is necessary for patients with chronic hepatitis C
por: Maqsood, Muhammad H, et al.
Publicado: (2020)

Role of lower dose hepatitis B immune globulin prophylaxis in liver transplantation: A single center perspective
por: Edwards, Diep, et al.
Publicado: (2023)

Long‐term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation
por: Vasudevan, Abhinav, et al.
Publicado: (2018)

Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
por: Volpes, Riccardo, et al.
Publicado: (2020)

Entecavir and Hepatitis B Immune Globulin in Patients Undergoing Liver Transplantation for Chronic Hepatitis B
por: Perrillo, Robert, et al.
Publicado: (2013)

De Novo Superinfection of Hepatitis B Virus in an Anti-HBs Positive Patient with Recurrent Hepatitis C Following Liver Transplantation
por: Ha, Sung-Hae, et al.
Publicado: (2011)

Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation
por: Lou, Bin, et al.
Publicado: (2021)

Hepatitis B Vaccine and Immunoglobulin: Key Concepts
por: Das, Saibal, et al.
Publicado: (2019)

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence
por: Takaki, Akinobu, et al.
Publicado: (2015)

Follow-Up of Newborns with Hepatitis B Antigenemia
por: Qi, Jing, et al.
Publicado: (2022)

Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature
por: Dehghani, Seyed Mohsen, et al.
Publicado: (2013)

Recurrence of hepatitis C after liver transplantation
por: Vinaixa, Carmen, et al.
Publicado: (2013)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
por: Lu, Ying, et al.
Publicado: (2021)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Misleading hepatitis B testing in the setting of intravenous immunoglobulin
por: Ilboudo, Christelle M, et al.
Publicado: (2013)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
por: Chen, Zhitao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ppaio4vpbrcoq0bnf9rdguq43p